Editorial: safety and efficacy of infliximab and corticosteroids in checkpoint inhibitor-induced colitis—authors' reply

Emilie K. Dahl; Osama K. Abed; Jens Kjeldsen; Marco Donia; Inge M. Svane; Anders Dige; Jørgen S. Agnholt; Jacob T. Bjerrum; Jakob B. Seidelin

doi:10.1111/apt.17250

Editorial: safety and efficacy of infliximab and corticosteroids in checkpoint inhibitor-induced colitis—authors' reply

Emilie K. Dahl^*, Osama K. Abed, Jens Kjeldsen, Marco Donia, Inge M. Svane, Anders Dige, Jørgen S. Agnholt, Jacob T. Bjerrum, Jakob B. Seidelin

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › Research › peer-review

1 Citation (Scopus)

Original language	English
Journal	Alimentary Pharmacology and Therapeutics
Volume	57
Issue number	1
Pages (from-to)	152-153
Number of pages	2
ISSN	0269-2813
DOIs	https://doi.org/10.1111/apt.17250
Publication status	Published - Jan 2023

Access to Document

10.1111/apt.17250

Cite this

Editorial : safety and efficacy of infliximab and corticosteroids in checkpoint inhibitor-induced colitis—authors' reply. / Dahl, Emilie K.; Abed, Osama K.; Kjeldsen, Jens; Donia, Marco ; Svane, Inge M.; Dige, Anders; Agnholt, Jørgen S.; Bjerrum, Jacob T.; Seidelin, Jakob B.

In: Alimentary Pharmacology and Therapeutics, Vol. 57, No. 1, 01.2023, p. 152-153.

Research output: Contribution to journal › Editorial › Research › peer-review

Dahl, Emilie K. ; Abed, Osama K. ; Kjeldsen, Jens ; Donia, Marco ; Svane, Inge M. ; Dige, Anders ; Agnholt, Jørgen S. ; Bjerrum, Jacob T. ; Seidelin, Jakob B. / Editorial : safety and efficacy of infliximab and corticosteroids in checkpoint inhibitor-induced colitis—authors' reply. In: Alimentary Pharmacology and Therapeutics. 2023 ; Vol. 57, No. 1. pp. 152-153.

@article{74ca5e96e31746659e15bf2ae4b94a7f,

title = "Editorial: safety and efficacy of infliximab and corticosteroids in checkpoint inhibitor-induced colitis—authors' reply",

author = "Dahl, {Emilie K.} and Abed, {Osama K.} and Jens Kjeldsen and Marco Donia and Svane, {Inge M.} and Anders Dige and Agnholt, {J{\o}rgen S.} and Bjerrum, {Jacob T.} and Seidelin, {Jakob B.}",

year = "2023",

month = jan,

doi = "10.1111/apt.17250",

language = "English",

volume = "57",

pages = "152--153",

journal = "Alimentary Pharmacology and Therapeutics, Supplement",

issn = "0953-0673",

publisher = "Wiley-Blackwell",

number = "1",

}

TY - JOUR

T1 - Editorial

T2 - safety and efficacy of infliximab and corticosteroids in checkpoint inhibitor-induced colitis—authors' reply

AU - Dahl, Emilie K.

AU - Abed, Osama K.

AU - Kjeldsen, Jens

AU - Donia, Marco

AU - Svane, Inge M.

AU - Dige, Anders

AU - Agnholt, Jørgen S.

AU - Bjerrum, Jacob T.

AU - Seidelin, Jakob B.

PY - 2023/1

Y1 - 2023/1

U2 - 10.1111/apt.17250

DO - 10.1111/apt.17250

M3 - Editorial

C2 - 36468203

AN - SCOPUS:85143645309

VL - 57

SP - 152

EP - 153

JO - Alimentary Pharmacology and Therapeutics, Supplement

JF - Alimentary Pharmacology and Therapeutics, Supplement

SN - 0953-0673

IS - 1

ER -